API0233068

Trilaciclib dihydrochloride

Trilaciclib dihydrochloride is a CDK4/6 inhibitor used to reduce chemotherapy-induced myelosuppression.

Product Size

Quantity

Pharm Gradet

Standard

Registration

Inquiry

API Description

API Details

Document

Related Patent Status

Molecular Weight (g/mol)

519.5
Molecular Formula

C24H32Cl2N8O
InChI

InChI=1S/C24H30N8O.2ClH/c1-30-9-11-31(12-10-30)18-5-6-20(25-15-18)28-23-26-14-17-13-19-22(33)27-16-24(7-3-2-4-8-24)32(19)21(17)29-23;;/h5-6,13-15H,2-4,7-12,16H2,1H3,(H,27,33)(H,25,26,28,29);2*1H
InChIKey

BRCYOXKEDFAUSA-UHFFFAOYSA-N
SMILES

CN1CCN(CC1)C2=CN=C(C=C2)NC3=NC=C4C=C5C(=O)NCC6(N5C4=N3)CCCCC6.Cl.Cl
IUPAC Name

4-[[5-(4-methylpiperazin-1-yl)pyridin-2-yl]amino]spiro[1,3,5,11-tetrazatricyclo[7.4.0.02,7]trideca-2,4,6,8-tetraene-13,1'-cyclohexane]-10-one;dihydrochloride
Exact Mass (Da)

518.2076131
Monoisotopic Mass (Da)

518.2076131

OUR PRODUCTS